Evidence map›Paper›PMID 37225928›Full record

ArticleClinical rheumatology2023

Ultrasonography in the diagnosis of suspected primary Sjögren's syndrome and concordance with salivary gland biopsy: a Spanish single-center study.

Laura Barrio-Nogal, Marta Novella-Navarro, Cristina Bohórquez Heras, Luis Sala-Icardo, Enrique Calvo-Aranda, Ana Pérez Gómez

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Laura Barrio-NogalRheumatology Department, Hospital Universitario de Torrejón, Madrid, Spain. labano_1990@hotmail.com.ORCID http://orcid.org/0000-0002-2429-407X
Marta Novella-NavarroRheumatology Department, Hospital Universitario de La Paz, Madrid, Spain.ORCID http://orcid.org/0000-0002-2200-0859
Cristina Bohórquez HerasRheumatology Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain.
Luis Sala-IcardoRheumatology Department, Hospital Universitario de Torrejón, Madrid, Spain.ORCID http://orcid.org/0000-0002-5738-7133
Enrique Calvo-ArandaRheumatology Department, Hospital Universitario Infanta Leonor, Madrid, Spain.ORCID http://orcid.org/0000-0002-3095-0969
Ana Pérez GómezRheumatology Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain.
Hospital Universitario de Torrejón · ESHospital Universitario Príncipe de Asturias · ESHospital Universitario Infanta Leonor · ESHospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study aims to evaluate the utility of major salivary gland ultrasonography for diagnosis of primary Sjögren's syndrome (pSS) and to assess its concordance with minor salivary gland biopsy (MSGB).

methodsA cross-sectional study of 72 patients with suspected pSS was performed. Demographic, clinical, and serological data were collected. MSGB was performed, as was ultrasonography. The ultrasound technician was blind to clinical, serological, and histological data. The validity of ultrasonography compared with MSGB, the American-European Consensus Group (AECG), and American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) criteria was assessed by calculating the percentage of agreement, sensitivity, specificity, positive and negative predictive values, and area under the curve (AUC).

resultsBased on MSGB as the gold standard, the percentage of agreement between both tests was 78% (AUC 0.75). Based on the ACR/EULAR criteria, the percentage of agreement was 83% (AUC 0.78) for ultrasonography and 81% (AUC 0.83) for biopsy. Sensitivity and specificity were 90% and 67%, respectively, for ultrasonography and 76% and 90% for biopsy. The results were similar with the AECG criteria. The intra- and inter-observer variability was good (κ > 0.7). Significant differences were observed for positive anti-Ro52 values and hypergammaglobulinemia in pathological ultrasound scans.

conclusionDiagnostic ultrasonography is as useful as MSGB in pSS. Therefore, it could be included in the classification criteria. In this cohort, it proved more sensitive than MSGB and could be used as an initial test for patients suspected of having pSS. MSGB could be used in cases where clinical and serological results are inconclusive. Key Points • Major salivary gland ultrasonography adds diagnostic value similar to that of MSGB, thus potentially enabling this invasive procedure to be avoided. • Ultrasonography could be included in the classification criteria for primary Sjögren's syndrome. • Given that ultrasonography is more sensitive and less specific than MSGB, it could be used as an initial diagnostic test in patients with suspected Sjögren's syndrome. • Biopsy should be performed in those cases where ultrasonography, clinical, and serological data are inconclusive.

Indexed as

Sjogren's SyndromeBiopsyCross-Sectional StudiesGuanidinesHumansSalivary GlandsUltrasonography2'-carbomethoxyphenyl 4-guanidinobenzoateGuanidinesDiagnosisMinor salivary gland biopsySjögren syndromeUltrasonography

Identifiers

PMID37225928
OpenAlexW4378173006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.